Europe Biomanufacturing Viral Detection and Quantification Market - Analysis and Forecast, 2023-2032

Report
81 Pages
November 2023
Region: Europe
BIS Research
ID: 5914401

The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032. The growing use of biopharmaceutical products and improvements in viral testing technologies are expected to drive the growth of the biomanufacturing viral detection and quantification market in the European market.

Market Introduction

The market for viral detection and quantification biomanufacturing in Europe is expanding quickly as a result of the growing use of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products becomes increasingly important as the demand for biologics develops. Sturdy quality control procedures are necessary to comply with regulations and preserve product integrity. One such procedure is the measurement of viral contamination during biomanufacturing. As a result, the European biomanufacturing viral detection and quantification market is experiencing a surge in demand for consumables and instruments. With technological improvements and a commitment to upholding high standards, the market is well-positioned for ongoing growth in the area.

Market Segmentation:

Segmentation 1: by Offering Type

Consumables
Instruments
Services

Segmentation 2: by Technology

PCR
ELISA
Flow Cytometry
Plaque Assay
Others

Segmentation 3: by Application

Blood and Blood Products Manufacturing
Vaccines and Therapeutics Manufacturing
Cellular and Gene Therapy Products Manufacturing
Stem Cell Products Manufacturing
Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

Life Science Companies
Testing Laboratories
CROs and CDMOs

Segmentation 6: by Country

Germany
France
U.K.
Spain
Italy
Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the Europe biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

Merck KGaA
Sartorius AG
QIAGEN N.V.

This product will be delivered within 3-5 business days.

1 Product Definition

1.1 Inclusion and Exclusion Criteria

2 Market Scope

2.1 Key Questions Answered in the Report

3 Research Methodology

4 Europe

4.1 Overview
4.2 Europe
4.2.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
4.2.5.1 Germany
4.2.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.2 U.K.
4.2.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.3 France
4.2.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.4 Spain
4.2.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.5 Italy
4.2.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.6 Rest-of-Europe
4.2.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)

5 Markets - Competitive Benchmarking & Company Profiles

5.1 Overview
5.2 Company Share Analysis
5.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
5.4 Merck KGaA
5.4.1 Company Overview
5.4.2 Role of Merck KGaA in the Biomanufacturing Viral Detection and Quantification Market
5.4.3 Key Competitors
5.4.4 Financials
5.4.5 Key Insights about the Financial Health of the Company
5.4.6 Analyst Perspective
5.5 Sartorius AG
5.5.1 Company Overview
5.5.2 Role of Sartorius AG in the Biomanufacturing Viral Detection and Quantification Market
5.5.3 Key Competitors
5.5.4 Financials
5.5.5 Analyst Perspective
5.6 QIAGEN N.V.
5.6.1 Company Overview
5.6.2 Role of QIAGEN N.V. in the Biomanufacturing Viral Detection and Quantification Market
5.6.3 Key Competitors
5.6.4 Financials
5.6.5 Key Insights about the Financial Health of the Company
5.6.6 Analyst Perspective

List of Figures

Figure 1: Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 2: Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
Figure 3: Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
Figure 4: Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
Figure 5: Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
Figure 6: Biomanufacturing Viral Detection and Quantification Market (by Region), $Billion, 2022 and 2032
Figure 7: Biomanufacturing Viral Detection and Quantification Market: Research Methodology
Figure 8: Primary Research Methodology
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Top-Down Approach (Segment-Wise Analysis)
Figure 11: Biomanufacturing Viral Detection and Quantification Market (by Region)
Figure 12: Europe: Market Dynamics
Figure 13: Europe Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 14: Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 15: Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 16: Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 17: Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 18: Germany Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 19: Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 20: Germany Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 21: Germany Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 22: Germany Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 23: U.K. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 24: U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 25: U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 26: U.K. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 27: U.K. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 28: France Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 29: France Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 30: France Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 31: France Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 32: France Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 33: Spain Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 34: Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 35: Spain Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 36: Spain Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 37: Spain Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 38: Italy Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 39: Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 40: Italy Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 41: Italy Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 42: Italy Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 43: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 44: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 45: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 46: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 47: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 48: Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
Figure 49: Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
Figure 50: Merck KGaA: Product Portfolio
Figure 51: Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 52: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 53: Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 54: Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 55: Sartorius AG: Product Portfolio
Figure 56: Sartorius AG: Overall Financials, $Million, 2020-2022
Figure 57: Sartorius AG: Revenue (by Segment), $Million, 2020-2022
Figure 58: Sartorius AG: Revenue (by Region), $Million, 2020-2022
Figure 59: QIAGEN N.V.: Product Portfolio
Figure 60: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 61: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 62: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 63: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022

List of Tables

Table 1: Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
Table 2: Key Questions Answered in the Report

Executive Summary

The Europe biomanufacturing viral detection and quantification market is estimated to reach $345.9 million by 2032, reveals the premium market intelligence study. The study also highlights that the market is set to witness a CAGR of 9.80% during the forecast period 2023-2032.

The Europe Biomanufacturing Viral Detection and Quantification Market: Drivers and Challenges

Market Drivers

Research initiatives to enhance the accuracy, efficiency, and accessibility of viral testing assays
Technological advancements in viral detection and quantification

Market Restraints

Lack of consistent standards and guidelines for viral detection and quantification

USPs of report

Market ranking analysis based on product portfolios and recent developments

Analysis of business drivers and challenges of the Europe Biomanufacturing Viral Detection and Quantification Market
Detailed analysis of Biomanufacturing Viral Detection and Quantification Market for Germany, France, Italy, Spain, and U.K.
Segmentation by offering type, technology, application, and end user provided in the report

Analyst’s Perspective on Biomanufacturing Viral Detection and Quantification Market

The Principal Analyst states, 'The biomanufacturing viral detection and quantification market is experiencing rapid growth due to the increasing utilization of biopharmaceuticals. Robust quality control processes are essential to ensure the safety, efficacy, and consistency of biologics. The market is driven by the need for stringent QC measures throughout the manufacturing journey, advancements in testing technologies, and expanding regulatory frameworks. The biomanufacturing viral detection and quantification market has witnessed a steady growth in the number of new entrants and investments in biopharmaceuticals, thereby driving a surge in demand for the products and services required in the manufacturing and QC of biologics. This trend is also expected to continue over the forecast period. Therefore, the impact of the aforementioned factors is expected to drive the biomanufacturing viral detection and quantification market in the near future.'

Some of the prominent names in this market are:

Merck KGaA
Sartorius AG
QIAGEN N.V.

Key Questions Answered in the Report

What are the key drivers, restraints, and opportunities for Europe biomanufacturing viral detection and quantification market? What will be their impact on the market in the short, mid, and long-term duration?
Which offering type is projected to be the fastest-growing segment during the forecast period 2023-2032?
Who are the key players in the Europe biomanufacturing viral detection and quantification market, and what are their product offerings in the market?

Companies Mentioned

Merck KGaA
Sartorius AG
QIAGEN N.V.

Table Information

Report Attribute	Details
No. of Pages	81
Published	November 2023
Forecast Period	2023 - 2032
Estimated Market Value ( USD ) in 2023	$ 149.2 Million
Forecasted Market Value ( USD ) by 2032	$ 345.9 Million
Compound Annual Growth Rate	9.8%
Regions Covered	Europe
No. of Companies Mentioned	3

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€2369EUR$2,450USD£2,007GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€3820EUR$3,950USD£3,235GBP

Market Introduction

Market Segmentation:

Segmentation 1: by Offering Type

Segmentation 2: by Technology

Segmentation 3: by Application

Segmentation 4: by End User

Segmentation 6: by Country

How can this report add value to an organization?

Key Market Players and Competition Synopsis

Some of the prominent names in this market are:

Table of Contents

Executive Summary

The Europe Biomanufacturing Viral Detection and Quantification Market: Drivers and Challenges

Market Drivers

Market Restraints

USPs of report

Market ranking analysis based on product portfolios and recent developments

Analyst’s Perspective on Biomanufacturing Viral Detection and Quantification Market

Some of the prominent names in this market are:

Key Questions Answered in the Report

Companies Mentioned

Table Information

Related Topics

Related Reports

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032

Global Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Forecast 2024-2030

Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow, Indication, Culture Type, and Region - Analysis and Forecast, 2023-2033

Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030